ASES study

A pilot study to evaluate the extent of analgesia after Sacral-Erector Spinae Peripheral Block Acronym (ASES) Study - ASES

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/031949

Enrollment

Registered

2021-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Sacral erector spinae block: Usual pre-surgical preparation will be done for the patients. Additional pre-surgical antibiotics will be administered as per indication based on the radiat

Eligibility

Inclusion criteria

Inclusion criteria: Patients of carcinoma cervix scheduled for intracavitary application

Exclusion criteria

Exclusion criteria: known coagulation disorders or thrombocytopenia, known allergy to any of the drugs involved in the study, visible excoriation/ skin changes over the sacral area.

Design outcomes

Primary

Measure	Time frame
Clinical effect of sacral erector spinae block in terms of dermatomal analgesiaTimepoint: Baseline, at 1 hr, 6 hrs, 12 hrs and 24 hRS from the block	—

Secondary

Measure	Time frame
Radiological evidence of contrast agent spread through CT scanTimepoint: 1 hour after the block	—

Countries

India

Contacts

Public ContactArunangshu Chakraborty

Tata Medical Center

dr.arunangshu@gmail.com8910324933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026